Robert D. MacKenzie

455 total citations
24 papers, 372 citations indexed

About

Robert D. MacKenzie is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Robert D. MacKenzie has authored 24 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Robert D. MacKenzie's work include Synthesis of β-Lactam Compounds (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Robert D. MacKenzie is often cited by papers focused on Synthesis of β-Lactam Compounds (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Robert D. MacKenzie collaborates with scholars based in United States. Robert D. MacKenzie's co-authors include Thomas R. Blohm, C.A. Hoppert, Richard U. Byerrum, R. F. Langham, R. A. Anwar, W. R. McGrath, J. Martin Grisar, Michael G. Moront, Robert B. Wallace and Nevin Katz and has published in prestigious journals such as Journal of Medicinal Chemistry, American Journal of Obstetrics and Gynecology and The American Journal of Cardiology.

In The Last Decade

Robert D. MacKenzie

24 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert D. MacKenzie United States 9 95 89 84 40 34 24 372
Masuo Tobe Japan 10 72 0.8× 113 1.3× 39 0.5× 14 0.3× 5 0.1× 45 360
K Satoh Japan 12 81 0.9× 112 1.3× 77 0.9× 29 0.7× 4 0.1× 33 551
Philip S. Thayer United States 12 205 2.2× 39 0.4× 16 0.2× 38 0.9× 11 0.3× 23 478
Agnes B. Russfield United States 12 110 1.2× 68 0.8× 54 0.6× 13 0.3× 6 0.2× 39 534
Fumio Sagami Japan 12 136 1.4× 51 0.6× 26 0.3× 29 0.7× 7 0.2× 44 410
Tatsuo Ishida Japan 9 65 0.7× 55 0.6× 64 0.8× 16 0.4× 215 6.3× 15 412
Martin D. Sass United States 13 130 1.4× 15 0.2× 66 0.8× 11 0.3× 9 0.3× 28 552
Stewart MacLeod United States 12 236 2.5× 54 0.6× 42 0.5× 30 0.8× 10 0.3× 17 512
U. Plappert Germany 12 163 1.7× 164 1.8× 23 0.3× 17 0.4× 6 0.2× 16 592
Igor Shmarakov Ukraine 13 231 2.4× 56 0.6× 67 0.8× 33 0.8× 10 0.3× 38 709

Countries citing papers authored by Robert D. MacKenzie

Since Specialization
Citations

This map shows the geographic impact of Robert D. MacKenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. MacKenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. MacKenzie more than expected).

Fields of papers citing papers by Robert D. MacKenzie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. MacKenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. MacKenzie. The network helps show where Robert D. MacKenzie may publish in the future.

Co-authorship network of co-authors of Robert D. MacKenzie

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. MacKenzie. A scholar is included among the top collaborators of Robert D. MacKenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. MacKenzie. Robert D. MacKenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Christopher, Michael J. Ashton, Raymond C. Bush, et al.. (1996). RP 73163: A bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor. Bioorganic & Medicinal Chemistry Letters. 6(1). 47–50. 11 indexed citations
2.
Grisar, J. Martin, et al.. (1977). ChemInform Abstract: (2‐PIPERIDINE)‐ AND (2‐PYRROLIDINE)ETHANONES AND ‐ETHANOLS AS INHIBITORS OF BLOOD PLATELETS AGGREGATION. Chemischer Informationsdienst. 8(5). 1 indexed citations
3.
Grisar, J. Martin, et al.. (1976). Substituted .alpha.-methylbenzyl and tricyclic arylalkyl lactamimides as inhibitors of blood platelet aggregation. Journal of Medicinal Chemistry. 19(4). 503–508. 7 indexed citations
4.
Grisar, J. Martin, et al.. (1976). ChemInform Abstract: SUBSTITUTED α‐METHYLBENZYL AND TRICYCLIC ARYLALKYL LACTAMIMIDES AS INHIBITORS OF BLOOD PLATELET AGGREGATION. Chemischer Informationsdienst. 7(31). 1 indexed citations
5.
Grisar, J. Martin, et al.. (1976). (2-Piperidine)- and (2-pyrrolidine)ethanones and -ethanols as inhibitors of blood platelets aggregation. Journal of Medicinal Chemistry. 19(10). 1195–1201. 9 indexed citations
6.
MacKenzie, Robert D., et al.. (1976). An In Vitro Method for Screening Compounds for the Effect on the Rate of Sickling of Erythrocytes. Journal of International Medical Research. 4(6). 375–381. 4 indexed citations
7.
MacKenzie, Robert D., et al.. (1974). Evaluation of a quantitative platelet-collagen adhesiveness test system. Thrombosis Research. 5(2). 99–109. 9 indexed citations
8.
MacKenzie, Robert D., et al.. (1974). The effect on blood coagulation of ovariectomy and hysterectomy in rats given ethinyl estradiol. American Journal of Obstetrics and Gynecology. 118(8). 1041–1049. 2 indexed citations
9.
MacKenzie, Robert D., et al.. (1973). Substituted 3,4-pentadienyldiamines as inhibitors of platelet aggregation. Journal of Medicinal Chemistry. 16(6). 688–693. 4 indexed citations
10.
Grisar, J. Martin, et al.. (1973). Benzhydryl and fluorenyl lactamimides with hypoglycemic, diuretic, blood platelet aggregation inhibitory, and antiinflammatory activities. Journal of Medicinal Chemistry. 16(8). 885–893. 8 indexed citations
11.
Grisar, J. Martin, et al.. (1972). Naphthylalkyl lactamimides as inhibitors of blood platelet aggregation. Journal of Medicinal Chemistry. 15(12). 1270–1273. 3 indexed citations
12.
MacKenzie, Robert D., et al.. (1972). Effects in vivo of α-[p-(fluoren-9-ylidenemethyl)phenyl]-2-piperidineethanol (RMI 10,393) on platelet aggregation and blood coagulation. Biochemical Pharmacology. 21(5). 707–717. 2 indexed citations
13.
MacKenzie, Robert D., et al.. (1971). Effects of  -(p-(Fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10,393) on Platelet Function. Experimental Biology and Medicine. 137(2). 662–667. 5 indexed citations
14.
MacKenzie, Robert D., et al.. (1971). A Modified Stypven Test for the Determination of Platelet Factor 3. American Journal of Clinical Pathology. 55(5). 551–554. 6 indexed citations
15.
MacKenzie, Robert D., et al.. (1969). The evaluation of a new rapid plasma lipase assay system. Biochemical Medicine. 2(6). 413–426. 3 indexed citations
16.
MacKenzie, Robert D., et al.. (1967). Rapid colorimetric micromethod for free fatty acids. Journal of Lipid Research. 8(6). 589–597. 48 indexed citations
17.
Blohm, Thomas R., Takashi Kariya, & Robert D. MacKenzie. (1960). I. Excretory products of the sterol biosynthetic pathway in the MER-29-treated rat. Progress in Cardiovascular Diseases. 2(6). 519–523. 6 indexed citations
18.
MacKenzie, Robert D., R. A. Anwar, Richard U. Byerrum, & C.A. Hoppert. (1959). Absorption and distribution of Cr51 in the albino rat. Archives of Biochemistry and Biophysics. 79. 200–205. 38 indexed citations
19.
Blohm, Thomas R. & Robert D. MacKenzie. (1959). Specific inhibition of cholesterol biosynthesis by a synthetic compound (MER-29). Archives of Biochemistry and Biophysics. 85(1). 245–249. 90 indexed citations
20.
MacKenzie, Robert D., C.A. Hoppert, & Richard U. Byerrum. (1957). Studies of Cadmium and Chromium Solubility and Toxicity. American Water Works Association. 49(10). 1310–1312. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026